Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2025-04-23
DOI
https://doi.org/10.1186/s12876-025-03861-8
Citations
3
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
3.97

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance

Guangjie Han, Man Zhao, Jiaojiao Hou, Ning Li et al.
3 citations
BMC Gastroenterology
Hepatocellular Carcinoma Treatment and Prognosis
3.97
article

Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance

Guangjie Han, Man Zhao, Jiaojiao Hou, Ning Li, Jinfeng Wang, Fei Yin, Xiaoling Duan, Xin Han, Jianfei Shi, Lili Mi
article en
3 citations

Abstract

No abstract available for this paper.
BMC GastroenterologyVol. 25(1)
Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN)
Natural Science Foundation of Hebei Province
Good health and well-being
Openalex Percentile: Top 7%
Hepatocellular Carcinoma Treatment and Prognosis
3.97
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.